Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel M Rubinstein

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Lancet Regional Health. Americas|February 23, 2023
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer ConsortiumToni K Choueiri, Chris Labaki, Ziad Bakouny, et al.
Cancer Discovery|July 24, 2020
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort StudyDonna R Rivera, Solange Peters, Orestis A Panagiotou, et al.
The Lancet. Healthy Longevity|February 21, 2022
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer ConsortiumArielle Elkrief, Cassandra Hennessy, Nicole M Kuderer, et al.
The New England Journal of Medicine|June 15, 2026
Talquetamab-Daratumumab in Relapsed or Refractory MyelomaRoberto Mina, Meral Beksac, Paula Rodríguez-Otero, et al.
Blood Cancer Discovery|March 9, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, et al.
Lancet (London, England)|June 1, 2020
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyNicole M Kuderer, Toni K Choueiri, Dimpy P Shah, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Lancet Regional Health. Americas|February 23, 2023
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer ConsortiumToni K Choueiri, Chris Labaki, Ziad Bakouny, et al.
Cancer Discovery|July 24, 2020
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort StudyDonna R Rivera, Solange Peters, Orestis A Panagiotou, et al.
The Lancet. Healthy Longevity|February 21, 2022
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer ConsortiumArielle Elkrief, Cassandra Hennessy, Nicole M Kuderer, et al.
The New England Journal of Medicine|June 15, 2026
Talquetamab-Daratumumab in Relapsed or Refractory MyelomaRoberto Mina, Meral Beksac, Paula Rodríguez-Otero, et al.
Blood Cancer Discovery|March 9, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, et al.
Lancet (London, England)|June 1, 2020
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyNicole M Kuderer, Toni K Choueiri, Dimpy P Shah, et al.
Pageof 6